Penumbra, Inc. (PEN)
332.42
+0.25
(+0.08%)
USD |
NYSE |
Apr 15, 16:00
333.33
+0.91
(+0.27%)
After-Hours: 20:00
Penumbra Research and Development Expense (Annual) : 69.43M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp. | 2.052B |
| Intuitive Surgical, Inc. | 1.312B |
| Revvity, Inc. | 215.84M |
| Globus Medical, Inc. | 146.94M |
| Abbott Laboratories | 2.889B |